ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
Disease progression | 08.01.03.038 | 0.001250% | | |
Drug intolerance | 08.06.01.013 | - | - | Not Available |
Occult blood | 13.05.02.003 | - | - | Not Available |
Hyperlipidaemia | 14.08.03.001 | - | - | |
Urine analysis abnormal | 13.13.02.008 | - | - | Not Available |
Renal impairment | 20.01.03.010 | 0.003124% | | Not Available |
Skin haemorrhage | 24.07.01.103; 23.06.07.001 | 0.001250% | | Not Available |
Ulcerative keratitis | 10.02.01.021; 06.04.02.004 | - | - | |
Cytopenia | 01.03.03.012 | - | - | Not Available |
Treatment failure | 08.06.01.017 | 0.003374% | | Not Available |
Skin mass | 23.07.04.014 | - | - | Not Available |
Anorectal discomfort | 07.03.03.003 | - | - | Not Available |
Fasting | 26.01.02.001 | - | - | Not Available |
Drug-induced liver injury | 12.03.01.044; 09.01.07.023 | 0.001875% | | Not Available |
Candida infection | 11.03.03.021 | - | - | |
Excessive cerumen production | 04.01.01.004 | - | - | Not Available |
Liver function test increased | 13.03.04.031 | - | - | Not Available |
Malignant melanoma in situ | 23.08.01.004; 16.03.01.004 | 0.001250% | | Not Available |
Diabetic foot | 24.04.03.015; 23.07.03.008; 17.09.04.006; 14.07.06.001; 05.07.06.001 | - | - | Not Available |
Skin plaque | 23.03.03.044 | - | - | Not Available |
Toxic goitre | 14.11.01.046; 05.02.02.006 | 0.001250% | | Not Available |
Burning feet syndrome | 15.03.04.019; 23.06.05.010; 17.02.06.038 | - | - | Not Available |
Cutaneous T-cell lymphoma | 23.07.04.029; 16.17.03.002; 01.11.03.002 | 0.001875% | | Not Available |
Differentiation syndrome | 22.02.01.036; 16.32.03.037; 12.03.01.063; 08.01.07.016 | 0.003124% | | Not Available |
Diffuse idiopathic skeletal hyperostosis | 15.01.09.006 | 0.001250% | | Not Available |
Drug ineffective for unapproved indication | 12.09.02.002; 08.06.01.038 | 0.001875% | | Not Available |
Idiopathic intracranial hypertension | 17.07.02.011 | 0.001250% | | Not Available |
Immune thrombocytopenia | 01.08.01.013; 10.02.01.083 | 0.001250% | | Not Available |
Therapeutic product effect decreased | 08.06.01.050 | - | - | Not Available |
Therapeutic product effect incomplete | 08.06.01.052 | 0.003124% | | Not Available |